Flexible fibreoptic bronchoscopy is an important tool in the evaluation and management of paediatric respiratory disease. Total intravenous anaesthesia (TIVA) and volatile agent induction and maintenance of anaesthesia (VIMA) are commonly used for these procedures. The aim of this study was to determine which is superior for children undergoing flexible fibreoptic bronchoscopy.The study included two phases. In Phase 1, eD 99 of propofol in TIVA and eD 99 of sevoflurane in VIMA were first determined. In Phase 2, 50 children aged from one to three years were recruited and randomly assigned to either a TIVA or a VIMA group. An eD 99 dose of propofol with remifentanil was administered to the TIVA group and sevoflurane to the VIMA group. Haemodynamic variables, stress hormone responses, anaesthesia profiles, adverse reactions and physicians' levels of satisfaction were compared between the two groups. The eD 99 values of propofol in the TIVA group and sevoflurane in the VIMA group were 8.9 µg/ml and 6.8% respectively. Haemodynamic variables and stress hormone levels were higher in the VIMA group than in the TIVA group. Agitation and coughing also occurred less frequently in the TIVA group. In addition, physicians' levels of satisfaction were greater in the TIVA group. Our results suggest that TIVA with propofol plus remifentanil is superior to VIMA using sevoflurane alone for children undergoing flexible fibreoptic bronchoscopy.
Flexible fibreoptic bronchoscopy (FFB) has been well documented as an important technology in the evaluation and management of paediatric respiratory disease for over 30 years 1, 2 . Due to non co-operation and distress, most children need adequate sedation or general anaesthesia in order to facilitate the procedure. However, as FFB is a brief procedure, the use of long-acting sedation may impact hospital length-of-stay and increase resource use. In view of this, fast induction and emergence from anaesthesia is required. As a popular anaesthetic procedure, total intravenous anaesthesia (TIVA) consists mainly of a combination of a short-duration hypnotic and a short-duration analgesic agent, such as propofol plus remifentanil 3 , whereas volatile induction and maintenance of anaesthesia (VIMA) with sevoflurane has been used as an alternative to TIVA due to properties such as fast induction and emergence from anaesthesia, plus reduced respiratory depression 4 .
Some studies have reported that FFB can stimulate the release of stress hormones and render the patients' haemodynamic status unstable 5 . More seriously, it has been suggested that it may subject the child or adolescent to hypoxia, hypoxaemia and haemodynamic complications, which may be life-threatening [6] [7] [8] [9] . In view of this, inhibition of the neuroendocrine reaction to stress is important during FFB. TIVA, using propofol and remifentanil and sevoflurane anaesthesia could influence the release of stress response markers (cortisol, adrenaline and noradrenaline) in a low stress-level surgical procedure 10 , but whether these anaesthetic strategies can decrease the stress hormones in FFB is unknown.
The purpose of this prospective, randomised study was to compare the effects of these two anaesthetic techniques on peri-FFB anaesthetic profiles from induction to emergence, and also to examine the neurohormonal and haemodynamic responses to anaesthesia and FFB-related stress.
MeTHODS
The study protocol was approved by the Hubei Maternal and Child Health Hospital ethics Committee (Protocol No. 2012001) and registered at chictr.org (ChiCTR-TRC-12002557). This study was carried out at Hubei Maternal and Child Health Hospital and conducted according to the Decalration of Helsinka between October 2012 and March 2013. Written consent was obtained from all participants' parents or guardians before the trial.
Children aged from one to three years who were scheduled to undergo FFB were recruited. The inclusion criteria were persistent or recurrent atelectasis, pneumonia or bronchiostenosis and classified as American Society of Anesthesiologists (ASA) physical status 1 or 2. Children with a history of cardiovascular, endocrine, renal or hepatic disorders, allergy to opioids or current use of analgesics or psychoactive drugs were excluded from the study. In order to limit the confounding effects of diurnal variation, only patients undergoing FFB commencing during morning hours (0800 to 1200 hours) were investigated. Premedication was not used.
The study was divided into two phases ( Figure  1 ). In Phase 1, the eD 99 of propofol in the TIVA group and eD 99 of sevoflurane in the VIMA group were examined by probit analysis. In Phase 2, the two techniques were compared using the eD 99 as evaluated. As neuromuscular blocking drugs were not necessary for FFB, they were not applied in this study.
Phase 1-ED 99 of propofol in TIVA and ED 99 of sevoflurane in VIMA
For TIVA, children were randomised by a computer-generated list to receive one of five doses of propofol (4.0, 4.8, 5.8, 6.9 and 8.3 µg/ml effective site concentration, n=15 each). Allocation concealment was ensured by the use of coded, sealed opaque envelopes. One mg/kg of 1% lignocaine for reducing injection pain was administered before intravenous anaesthetics. At the beginning of anaesthesia induction, propofol was infused by an Asena PK Mk III infusion pump programmed according to the Paedfusor model (Alaris Medical Systems, Beijing, China). At the same time, remifentanil (Humanwell Pharmaceutical Co. Ltd, Yichang, China) 1 µg/kg was injected over 60 seconds, followed by an infusion of 0.4 µg/kg/minute. A laryngeal mask airway (LMA) was inserted followed by spontaneous ventilation (60% oxygen, 6 l/minute, Mapleson D circuit) when the lash reflex was absent and the jaw was relaxed. If the patient remained apnoeic for more than 30 seconds after LMA insertion, the lungs were manually ventilated via the LMA to maintain oxygen saturation (SpO 2 ) above 95% and end-tidal carbon dioxide tension between 35 and 45 mmHg, until spontaneous ventilation was regained. The bronchoscope was introduced through a bronchoscopy adaptor connected to the LMA after general anaesthesia had been established 2 . Topical lignocaine was sprayed to the glottis vera and trachea before FFB. After completion of FFB, all drugs were discontinued and the LMA was removed when the child was fully awake (older children responding to verbal commands; younger children crying; spontaneous eye-opening; purposeful movement). The level of success of anaesthesia for each group during induction and maintenance was recorded. Successful anaesthesia was defined as: 1) no bucking, nausea, vomiting, laryngospasm, bronchospasm, agitation and body movement during the maintenance of anaesthesia; and 2) no hypoxaemia (SpO 2 ≤90%) or hypercapnia (end-tidal carbon dioxide >45 mmHg). eD 99 of propofol was determined by the probit analysis using SPSS 12.0 (SPSS Inc, Chicago, IL, USA).
Hypotension, defined as a mean arterial pressure (MAP) <70% of the baseline value lasting for >5 minutes, was treated by increasing the level of fluid infusion and administration of intravenous phenylephrine 0.05 mg/kg. Hypertension, which was defined as a MAP >130% of the baseline value lasting for >5 minutes, was treated by the administration of intravenous remifentanil 1 µg/kg. A heart rate <80 beats/minute at any time was defined as bradycardia and treated with intravenous atropine 0.01 mg/kg. Children with hypertension received incremental remifentanil and were recorded as 'failures'.
For the VIMA group, induction of anaesthesia was carried out using 8% sevoflurane in oxygen (6 l/ minute oxygen primed with 8% sevoflurane) through a facemask. Manual ventilation was performed for three minutes before an appropriate-sized LMA was inserted. Anaesthesia was maintained for five minutes using end-tidal sevoflurane of 3.4, 4.0, 4.9, 5.8, 7.0% (60% oxygen, 6 l/minute, Mapleson D circuit) in five groups (n=15 each), respectively, before FFB was carried out. The level of success of anaesthesia for each group was recorded. The randomisation, LMA insertion, topical anaesthesia, process of FFB, removal of the LMA, success standard and probit analysis were identical to those in the TIVA group.
Phase 2-anaesthesia profiles, stress-induced hormone and haemodynamic responses during FFB: TIVA vs VIMA
Fifty children were randomly assigned to one of two groups (TIVA group or VIMA group, n=25 each). A 24-gauge catheter for blood sampling was inserted in the vein in the dorsum of the hand opposite the side used for intravenous fluid infusion in the paediatric intensive care unit or paediatric ward. A eutectic mixture of local anaesthetics (eMLA ® , AstraZeneca Pty Ltd, Shanghai, China) was applied to the skin one hour before puncturing. In the TIVA group, eD 99 dose of propofol (as well as remifentanil 1 µg/kg was injected over 60 seconds followed by an infusion of 0.4 µg/kg/minute) was administered by infusion pump while the VIMA group received an eD 99 dose of sevoflurane. These anaesthetic procedures were identical to those used in Phase 1. All anaesthetics were discontinued at the end of FFB. Children were evaluated for the recovery of consciousness at oneminute intervals while breathing 100% oxygen. After achieving adequate ventilation, the children were extubated when they were fully awake and transferred to the post-anaesthetic care unit. SpO 2 , bispectral index (BIS) and haemodynamic variables, including heart rate (HR) and MAP, were monitored and recorded at six time points: baseline (T 0 ), loss of the response to jaw thrust (T 1 ), LMA insertion (T 2 ), five minutes after the FFB commencing (T 3 ), ten minutes after FFB commencing (T 4 ) and 30 minutes after LMA removal (T 5 ). end-tidal carbon dioxide was recorded from T 1 to T 4 .
The duration of induction, defined as the time interval from the drug administration to loss of eyelash reflex, was measured. Recovery time, defined as the interval from completion of FFB to achievement of an Aldrete score of 9 was also recorded 12 . The anaesthesia was assessed at the end of the bronchoscopy by the examining physician, who employed a visual numerical scale ranging from 0 to 10; the high limit represented the best degree of satisfaction.
Induction, maintenance and emergence adverse reactions, including coughing, laryngospasm, nausea, vomiting, bronchospasm, agitation and any other unanticipated events, were recorded. Blood samples were taken at T 0 , T 1 , T 2 , T 3 , T 4 and T 5 for the measurement of plasma glucose, cortisol, adrenaline and noradrenaline. Blood samples were immediately cooled at 4°C, centrifuged within 20 minutes and stored at -70°C for later analysis. Plasma glucose was determined by the glucose oxidase method using a commercial Kit (Wuhan Xinqidi Biological Technology Co., Ltd, Wuhan, China); adrenaline, noradrenaline and cortisol were analysed using a chemiluminescence enzyme immunoassay method with a commercial kit (Wuhan Xinqidi Biological Technology Co., Ltd, Wuhan, China).
In order to determine sample size and statistical power, calculations were performed assuming a type 1 error rate of 0.05, power of 0.80 and the difference of rate of agitation in the two groups from our preliminary experiment. Data were expressed as mean ± standard deviation. Differences between and within the groups were analysed for statistical significance using SPSS 12.0 software. Age, weight, HR, MAP, SpO 2 and BIS value at baseline were compared by using an unpaired, two-tailed Student's t-test and sex distribution was analysed by using the chi-square test. end-tidal carbon dioxide, HR and MAP during observation periods were compared using a repeated-measures general linear model with a Huynh-Feldt correction for sphericity. Induction time, emergence time, duration of FFB and the examining physicians' scores were compared by using an independent-samples t-test and the incidence of adverse events were compared using the chi-square test. A P value <0.05 was considered significant.
ReSULTS
Of the 209 children scheduled to undergo FFB and eligible for enrolment in the study, nine were excluded because they refused to participate. Patients' demographic details are shown in Table 1 and anaesthetic induction and emergence profiles of Phase 2 are given in Table 2 . Although the duration of induction was shorter, the time to awakening in the TIVA group was significantly longer (P <0.05).
The eD 99 values of propofol in the TIVA group and sevoflurane in the VIMA group were 8.9 µg/ ml (95% confidence interval 7.8 to 12.3 µg/ml) and 6.8% (95% confidence interval 6.0 to 8.8%) respectively. Total propofol dose in the TIVA group was 20.5±2.9 mg. Most children in the TIVA group during Phase 2 had apnoea and needed respiratory support; however, only 40% of children in the VIMA group needed respiratory support. Anaesthetic characteristics, stress hormone responses and changes in plasma glucose in Phase 2 are shown in Table 3 . There were no statistically significant differences in BIS, CO 2 and SpO 2 between the two groups. MAP and HR were similar in both groups at T 0 and T 5 . The haemodynamic variables of the VIMA group rose from baseline and peaked at T 1 and then decreased. These variables were much higher than in the TIVA group at T 1 , T 2 , T 3 and T 4 . On the other hand, the variables in the TIVA group decreased from baseline and were significantly lower than in the VIMA group at T 1 to T 4 (P <0.05). Glucose, cortisol, adrenaline and noradrenaline in both groups decreased from baseline, but these variables were lower in the TIVA group than in the VIMA group at T 1 to T 5 .
Adverse reactions during anaesthesia in Phase 2 are shown in Table 4 . No side-effects of nausea or vomiting were observed in either group. Agitation occurred less frequently with propofol plus remifentanil than with sevoflurane during the induction and emergence periods (12 vs 96% in the induction period, P <0.001 and 4% vs 52% in the emergence period, P <0.001). Less coughing was observed in the TIVA group than in the VIMA group during the emergence period (24 vs 92%, P <0.001).
No bronchospasm occurred in either group, but there were two children who appeared to have laryngospasm in the TIVA group after LMA removal (P=0.49), although it disappeared after manual ventilation. The median anaesthesia scores by the physician in the TIVA group were higher than in the VIMA group (9.8±0.6 vs. 5.8±1.5, P <0.001).
DISCUSSION
Our study found that propofol-remifentanil TIVA required less induction time and had better stress hormone levels and haemodynamic characteristics with fewer complications when compared to sevoflurane in oxygen for FFB in children.
We used probit analysis to determine the effective dose of propofol and sevoflurane to sustain a satisfactory level of anaesthesia for FFB in children. As the probit method is suitable for analysing binomially distributed data 13 , it should be applicable to the proportions of paediatric patients in whom satisfactory anaesthesia was observed during FFB. Compared to Bandla's study, although larger doses of anaesthetics (effective site concentration of 8.9 µg/ml vs 50 to 150 µg/kg/min of propofol, 6.8% vs 2.5% to 3.5% with sevoflurane) were needed in both groups; fewer complications such as laryngospasm (4 vs 16%) were recorded in our study 14 , although a deeper level of anaesthesia might have played a major role in the low incidence of laryngospasm.
As small children and premature infants respond to painful stimuli 15 , appropriate management of pain and the attenuation of the stress response may lead to a reduced incidence of autonomic, catabolic, endocrine and immunosuppressive sequelae 16, 17 . Our study showed that although the release of stress-induced hormones could be inhibited in both groups, the haemodynamic variables during induction of anaesthesia differed markedly between the two groups. Induction with sevoflurane was associated with an abrupt increase in HR and MAP. This finding was, however, different to the results of studies examining adult volunteers with stable HR and MAP after being anaesthetised with sevoflurane 18, 19 . A possible explanation may be that children have a higher incidence of agitation compared to adults during sevoflurane anaesthesia and this may lead to more unstable haemodynamic characteristics.
Agitation is usually defined as "the occurrence, after loss of consciousness, of non-purposeful movements requiring restraint" 20 . This response is potentially dangerous to the child (self-injury, pulling out the intravenous line, damaging the surgical dressing etc), makes nursing and monitoring difficult, and is frightening for the child and parents/ guardians present in the recovery room. The incidence of agitation during induction and emergence was greater in the VIMA group than in the TIVA group, though the reason for this is not clear. At least five possible explanations could account for this observation. First, agitation is an effect of anaesthesia on the central nervous system, so seizure-like movements and electroencephalographic epileptiform activity might occur in patients induced with sevoflurane 21 . Next, Guedel's second stage of inhalation anaesthesia is more apparent with VIMA than with TIVA. During this period, a patient may be sensitive to environmental stimulation and this may be associated with an unstable haemodynamic status. Third, the rapid elimination of anaesthetics during emergence results in acute pain and anxiety 22 . In our study, emergence from propofol plus remifentanil anaesthesia in the TIVA group was slower than emergence from sevoflurane anaesthesia in the VIMA group. This could be due to an extended sedation and analgesia time which resulted in less agitation. Fourth, as the children were induced without their parents accompanying them, parental absence at induction could have made the children nervous and therefore resistant to inhalation with a mask. Finally, preoperative sedation with a benzodiazepine can decrease the occurrence of agitation 23 , but according to 'usual practice' in our hospital, no such drugs were administered during this study. The induction time was longer in the VIMA group compared with the TIVA group. This may reflect the time needed to acquire balance in the pulmonary alveoli, which was greater in comparison to the vein-brain. Our study also showed that the time of emergence was much greater in the TIVA group than in the VIMA group; this is in contrast to the findings of Ihn et al's study 11 . In our study, a neuromuscular blocking agent was not used and therefore a large dose of propofol was required to reduce the possible body movement which may account for the difference found.
Both groups had a high incidence of coughing, which could be a result of the stimulation of FFB to the airway. More post-FFB coughing was observed in the VIMA group than in the TIVA group. Our only possible explanation is that the children in the sevoflurane group had a faster time of emergence, whereas the children in the TIVA group may have experienced residual propofol sedation in the early stages of emergence.
The examining physicians of both groups (who were blind to the group allocation) were asked to express their degree of satisfaction with the anaesthesia using a visual numerical scale at the end of FFB.
The results suggest that they were more dissatisfied with VIMA, possibly because of the higher incidence of agitation observed during induction and emer-gence; other factors might be the smell of sevoflurane or more coughing after FFB in this group of children.
We acknowledge some limitations to the current study. First, although we determined sample size and statistical power before conducting the study, a much larger sample size would be able to detect subtle differences between the two procedures. Second, the depth of anaesthesia between TIVA and VIMA could be different, which probably accounted for the differences found. Remifentanil in paediatric patients has been shown to blunt the stress response to surgical stimuli effectively 24 . Lignocaine, as a local anaesthetic and class IB antiarrhythmic, can attenuate the cardiovascular response to FFB. In our study, lignocaine was employed to alleviate the pain of propofol injection; the use of remifentanil and lignocaine might lead to deeper anaesthesia and a more stable neurohormonal and haemodynamic response in the TIVA group. This might be a source of bias in the results we found, which tended to favour TIVA. We used the Paedfusor model for target-controlled infusion in children. Paedfusor is used routinely for the induction and maintenance of anaesthesia of children in our hospital, being both accurate and clinically effective 26 , although a drawback is that the Paedfusor does not suit children <1 year of age who have been anaesthetised with target-controlled infusion.
For future research, we suggest that the limitations mentioned above are addressed. In addition, we recommend that pre-procedural baseline levels of anxiety and agitation are graded and recorded preoperatively. Children <1 year or >3 years of age should also be recruited and included in future studies. 
CONCLUSION
Our results demonstrate that TIVA with propofol plus remifentanil was superior to VIMA with sevoflurane alone for FFB in children owing to faster, smoother induction rates, reduced stress hormone responses and fewer complications.
